[Retracted] Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway
- PMID: 38099365
- PMCID: PMC10781416
- DOI: 10.3892/ijmm.2023.5340
[Retracted] Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway
Abstract
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the immunofluorescence staining data shown in Fig. 3C, and the migration and invasion assay data shown in Figs. 4C and 4D were strikingly similar to data appearing in different form in other research articles written by different authors at different research institutes that had either already been published, or were submitted for publication at around the same time, one of which has been retracted. In addition, the western blotting data shown for the E‑cadherin and AKT protein bands in Fig. 5 were strikingly similar, albeit the bands had been flipped vertically. Owing to the fact that contentious data in the above article had already been submitted for publication elsewhere prior to its submission to International Journal of Molecular Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Molecular Medicine 44: 700‑708, 2020; DOI: 10.3892/ijmm.2020.4637].
Keywords: PI3K/AKT/mTOR pathway; colon carcinoma; epithelial‑mesenchymal transition; metastasis; xenograft mouse model.
Retraction of
-
Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.Int J Mol Med. 2020 Aug;46(2):700-708. doi: 10.3892/ijmm.2020.4637. Epub 2020 Jun 10. Int J Mol Med. 2020. Retraction in: Int J Mol Med. 2024 Feb;53(2):16. doi: 10.3892/ijmm.2023.5340. PMID: 32626924 Free PMC article. Retracted.
Similar articles
-
[Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4.Int J Mol Med. 2024 Mar;53(3):29. doi: 10.3892/ijmm.2024.5353. Epub 2024 Feb 1. Int J Mol Med. 2024. PMID: 38299238 Free PMC article.
-
[Retracted] Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.Int J Mol Med. 2024 Apr;53(4):31. doi: 10.3892/ijmm.2024.5355. Epub 2024 Feb 9. Int J Mol Med. 2024. PMID: 38334226 Free PMC article.
-
[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway.Mol Med Rep. 2024 Apr;29(4):60. doi: 10.3892/mmr.2024.13184. Epub 2024 Feb 23. Mol Med Rep. 2024. PMID: 38391013 Free PMC article.
-
[Retracted] Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells.Mol Med Rep. 2024 Apr;29(4):56. doi: 10.3892/mmr.2024.13180. Epub 2024 Feb 9. Mol Med Rep. 2024. PMID: 38334182 Free PMC article.
-
[Retracted] MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3.Mol Med Rep. 2023 Jul;28(1):138. doi: 10.3892/mmr.2023.13025. Epub 2023 Jun 2. Mol Med Rep. 2023. PMID: 37264958 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous